Skip to main content

Post-authorisation active surveillance of the Safety of COVID-19 Vaccine AstraZeneca (AZD-1222) in the UK: A consortium study

  • The aim of this study is to monitor the safety and utilisation of the COVID-19 Vaccine AstraZeneca (AZD-1222) administered to vaccines under real-world use in the UK
  • Recruitment is ongoing and flyers are being distributed at the Solebay Health Centre and The Beaches Medical Centre vaccination sites.

Cookie Notice

Find out more about how this website uses cookies to enhance your browsing experience.